Results 31 to 40 of about 10,280 (206)

International guidelines for the management ofANCA-associated systemic vasculitides

open access: yesСовременная ревматология, 2019
The paper deals with international guidelines for the management of antineutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitides (SVs) that are a group of severe life-threatening immune-mediated diseases. This group includes granulomatosis
T. V. Beketova
doaj   +1 more source

Update of Management of ANCA-Associated Vasculitis

open access: yesJournal of Clinical Rheumatology and Immunology, 2021
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is associated with significant morbidity and mortality. Management of AAV is divided into induction of remission and maintenance of remission.
Hoi San Tang, Shirley King Yee
doaj   +1 more source

The incidence, prevalence and mortality of granulomatosis with polyangiitis in the UK Clinical Practice Research Datalink [PDF]

open access: yes, 2016
Objectives: To estimate the incidence, prevalence and mortality of Granulomatosis with polyangiitis (GPA) in the United Kingdom. Methods: We conducted a historical cohort study using data from the Clinical Practice Research Datalink and Hospital Episode
Crooks   +11 more
core   +2 more sources

ANCA-associated vasculitis – Should we change the standard of care? [PDF]

open access: yes, 2015
Collaborative clinical trials over the last 25 years have revolutionised the care of patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. This has led to production of management recommendations and standards of care.
Bligny   +45 more
core   +1 more source

Asbestos and Probable Microscopic Polyangiitis

open access: yesCanadian Respiratory Journal, 2004
Several inorganic dust lung diseases (pneumoconioses) are associated with autoimmune diseases. Although autoimmune serological abnormalities are common in asbestosis, clinical autoimmune/collagen vascular diseases are not commonly reported.
George S Rashed Philteos   +4 more
doaj   +1 more source

Various patterns of acute alveolar haemorrhage in patients with microscopic polyangiitis: a clinicopathological study of four cases

open access: yesPolish Journal of Pathology, 2019
It is well known that acute alveolar haemorrhage (AAH) is attributed to capillaritis in most cases with microscopic polyangiitis (MPA). In this article, we explore the cause of alveolar haemorrhage in MPA patients. In the present study, we extracted four
Naoto Kuroda   +3 more
doaj   +1 more source

Current status of the treatment of microscopic polyangiitis and granulomatosis with polyangiitis in Japan [PDF]

open access: yes, 2012
This study aimed to describe the epidemiologic characteristics of microscopic polyangiitis (MPA) and granulomatosis with polyangiitis (GPA) in Japan.
Kurosawa, Michiko   +4 more
core   +1 more source

Microscopic polyangiitis presented with biopsy-confirmed pleuritis

open access: yesMonaldi Archives for Chest Disease, 2018
We describe a case of microscopic polyangiitis manifested as pleuritis confirmed by thoracoscopic biopsy. An 80-year-old man presented with a three-day history of shortness of breath and cough.
Naoto Ishimaru   +5 more
doaj   +1 more source

An immunogenetic perspective of ANCA-associated vasculitides

open access: yesEgyptian Rheumatology and Rehabilitation, 2022
Background Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV) are a group of small vessel vasculitides characterized by necrotizan vasculitis and inflammation.
A. Kocaaga, M. Kocaaga
doaj   +1 more source

Medial medullary infarction caused by antineutrophil cytoplasmic antibody-related vasculitis: Case report and review of the literature [PDF]

open access: yes, 2017
Rationale: Medial medullary infarction accounts for less than 1% of brain infarctions, and medial medullary infarctions is very rarely caused by antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis.Patient concerns: We report the case of a 76-
Ishii Kazuhiro   +7 more
core   +2 more sources

Home - About - Disclaimer - Privacy